BigHat Biosciences

BigHat Biosciences is a protein therapeutics company based in San Carlos, California, developing next-generation antibody drugs by pairing a high-throughput wet lab with machine learning. Its platform measures and optimizes antibodies for biophysical and functional properties such as affinity, stability and solubility, compressing design-build-test cycles from weeks or months to days. Founded in late 2019 by Mark DePristo and Peyton Greenside, the company advances its own therapeutic programs and co-development partnerships toward the clinic.

  • Series A
  • AI/ML
  • Biotechnology
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Sep 24, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Sep 24, 2026

    $75M

    Series C+

    Led by DFJ Growth

    • 8VC
    • Alexandria Venture Investments
    • Amgen Ventures
    • Andreessen Horowitz
    • Catalio Capital Management
    • DFJ Growth
    • Discovery Ventures
    • Eli Lilly and Company
    • GRIDS Capital
    • Intermountain Ventures
    • LG Technology Ventures
    • Merck Global Health Innovation Fund
    • Premji Invest
    • Quadrille Capital
    • Section 32
    • Sigmas Group

    Article coming soon.

Pricing

Research BigHat Biosciences — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Get started

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Get started

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if BigHat Biosciences is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

Start freeAll fundingVisit website
© 2026 VeilStrat. All rights reserved.All systems operational